Teladoc Health, Inc.
TDOC
$6.81
-$0.09-1.30%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -334.44% | -354.35% | 75.47% | 74.97% | 96.70% |
| Total Depreciation and Amortization | -18.16% | -6.00% | 10.52% | 27.46% | 24.29% |
| Total Amortization of Deferred Charges | 48.15% | 60.37% | 48.22% | 57.45% | 73.63% |
| Total Other Non-Cash Items | 383.88% | 351.56% | -75.80% | -75.42% | -97.16% |
| Change in Net Operating Assets | -955.79% | -411.90% | -58.36% | -65.07% | 136.68% |
| Cash from Operations | -13.04% | -16.10% | 18.34% | 37.21% | 47.65% |
| Capital Expenditure | -20.65% | 5.88% | 62.71% | 28.23% | 31.35% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.85% | 21.83% | 20.72% | 22.11% | 20.42% |
| Cash from Investing | -44.84% | 20.66% | 24.65% | 22.60% | 21.29% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -21.94% | -23.73% | -43.59% | -9.09% | 15.27% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 78.80% | 99.28% | -179.43% | -259.65% | 82.16% |
| Cash from Financing | -20.77% | -23.42% | -73.67% | -29.64% | 31.53% |
| Foreign Exchange rate Adjustments | -245.13% | -440.73% | -10.14% | -147.96% | 116.82% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -54.43% | -15.01% | 62.98% | 162.71% | 301.57% |